For example, LGR5-targeted antibody–drug conjugates were demonstrated to induce cytotoxicity in LGR5-high gastrointestinal cancer cells and decrease tumor size and proliferation in colon cancer xenograft models [181,182]. This evidence concerns the gene LGR5 and neoplasm.